IL98391A - Phenylacetylenes are converted into their preparation and pharmaceutical preparations containing them - Google Patents

Phenylacetylenes are converted into their preparation and pharmaceutical preparations containing them

Info

Publication number
IL98391A
IL98391A IL9839191A IL9839191A IL98391A IL 98391 A IL98391 A IL 98391A IL 9839191 A IL9839191 A IL 9839191A IL 9839191 A IL9839191 A IL 9839191A IL 98391 A IL98391 A IL 98391A
Authority
IL
Israel
Prior art keywords
formula
group
substituted
compound
aromat
Prior art date
Application number
IL9839191A
Other languages
English (en)
Hebrew (he)
Other versions
IL98391A0 (en
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of IL98391A0 publication Critical patent/IL98391A0/xx
Publication of IL98391A publication Critical patent/IL98391A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Silicon Polymers (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
IL9839191A 1990-07-26 1991-06-06 Phenylacetylenes are converted into their preparation and pharmaceutical preparations containing them IL98391A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4023742A DE4023742A1 (de) 1990-07-26 1990-07-26 Substituierte phenylacetylene, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel

Publications (2)

Publication Number Publication Date
IL98391A0 IL98391A0 (en) 1992-07-15
IL98391A true IL98391A (en) 1995-05-26

Family

ID=6411049

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9839191A IL98391A (en) 1990-07-26 1991-06-06 Phenylacetylenes are converted into their preparation and pharmaceutical preparations containing them

Country Status (20)

Country Link
US (1) US5202349A (fi)
EP (1) EP0468281B1 (fi)
JP (1) JP3140494B2 (fi)
KR (1) KR920002530A (fi)
AT (1) ATE119519T1 (fi)
AU (1) AU637513B2 (fi)
CA (1) CA2043823A1 (fi)
DE (2) DE4023742A1 (fi)
DK (1) DK0468281T3 (fi)
ES (1) ES2072487T3 (fi)
FI (1) FI913565A (fi)
GR (1) GR3015350T3 (fi)
HK (1) HK1005180A1 (fi)
HU (1) HUT58047A (fi)
IE (1) IE911904A1 (fi)
IL (1) IL98391A (fi)
NZ (1) NZ238784A (fi)
PT (1) PT98466A (fi)
RU (1) RU2014323C1 (fi)
ZA (1) ZA914386B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4210332C1 (fi) * 1992-03-30 1993-07-15 Gruenenthal Gmbh, 5100 Aachen, De
DE4308535A1 (de) * 1992-03-30 1993-10-07 Volkswagen Ag Brennkraftmaschine mit einem desaktivierbaren Ladungswechselventil
US5288751A (en) * 1992-11-06 1994-02-22 Abbott Laboratories [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis
JP3487858B2 (ja) * 1993-11-05 2004-01-19 アボツト・ラボラトリーズ Ｎ−［４−［（置換フェニル）アルキルチエニル］−及びｎ−４−［（置換フェニル）アルキルフリル］−ブト−３−イン−２−イル］−ｎ−ヒドロキシ尿素化合物の製造方法
CA2383524C (en) * 1999-08-31 2010-09-28 Merck & Co., Inc. Thiazolyl alkynyl compounds and methods of use thereof
US7105467B2 (en) * 2003-07-08 2006-09-12 Pharmacore, Inc. Nickel catalyzed cross-coupling reactions between organomagnesium compounds and anisole derivatives
US7105707B2 (en) * 2003-12-17 2006-09-12 Pharmacore, Inc. Process for preparing alkynyl-substituted aromatic and heterocyclic compounds
US8299307B2 (en) 2007-06-29 2012-10-30 Acucela Inc. Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
JP2014091025A (ja) * 2012-10-31 2014-05-19 Jet's Co Ltd アクセサリー用の玉、及びこれを用いたアクセサリー

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406691A (en) * 1979-12-18 1983-09-27 Ciba-Geigy Corporation Herbicidal ethynyl-phenylureas
HU201300B (en) * 1985-03-16 1990-10-28 Wellcome Found Process for production of derivatives of aryl and medical compositions containing them as active substance
DE3515278A1 (de) * 1985-04-27 1986-10-30 Grünenthal GmbH, 5190 Stolberg Neue benzoesaeurederivate, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel
GB8619593D0 (en) * 1986-08-12 1986-09-24 Roussel Lab Ltd Chemical compounds
US4897422A (en) * 1987-02-10 1990-01-30 Abbott Laboratories Lipoxygenase inhibiting compounds
DE3888574T2 (de) * 1987-04-24 1994-06-30 Abbott Lab Harnstoff-Derivate mit lipoxygenasehemmender Wirkung.
US5068251A (en) * 1988-12-16 1991-11-26 Abbott Laboratories Lipoxygenase inhibiting compounds
JPH04504261A (ja) * 1989-03-30 1992-07-30 アボツト・ラボラトリーズ 尿素系リポキシゲナーゼ阻害化合物

Also Published As

Publication number Publication date
AU8033391A (en) 1992-01-30
GR3015350T3 (en) 1995-06-30
PT98466A (pt) 1992-05-29
EP0468281A1 (de) 1992-01-29
CA2043823A1 (en) 1992-01-27
HU912296D0 (en) 1991-12-30
US5202349A (en) 1993-04-13
JPH04243856A (ja) 1992-08-31
JP3140494B2 (ja) 2001-03-05
NZ238784A (en) 1993-04-28
DE4023742A1 (de) 1992-01-30
FI913565A (fi) 1992-01-27
ES2072487T3 (es) 1995-07-16
IL98391A0 (en) 1992-07-15
RU2014323C1 (ru) 1994-06-15
DK0468281T3 (da) 1995-05-22
ATE119519T1 (de) 1995-03-15
DE59104848D1 (de) 1995-04-13
ZA914386B (en) 1992-04-29
IE911904A1 (en) 1992-01-29
HK1005180A1 (en) 1998-12-24
AU637513B2 (en) 1993-05-27
KR920002530A (ko) 1992-02-28
EP0468281B1 (de) 1995-03-08
FI913565A0 (fi) 1991-07-25
HUT58047A (en) 1992-01-28

Similar Documents

Publication Publication Date Title
FI77018B (fi) Analogifoerfarande foer framstaellning av antidepressivt aktiv (-)-enantiomer av n-metyl-n-/3-(2-metylfenoxi) -3-fenylpropyl/amin och dess farmaceutiskt godtagbara salt.
NZ215487A (en) Aryl derivatives, pharmaceutical compositions thereof and preservation of cut flowers
CA2554610A1 (fr) Derives d'aryl- et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application comme inhibiteurs de l'enzyme faah
US5326770A (en) Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals
US5750565A (en) Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
EP2167083B1 (en) 1- heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
CA2552565A1 (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
US5703093A (en) Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5824698A (en) Antibacterial dibenzimidazole derivatives
WO2012012322A1 (en) Substituted hydroxamic acids and uses thereof
MXPA97003634A (en) Derivatives of antibacterial benzymidazole
IL98391A (en) Phenylacetylenes are converted into their preparation and pharmaceutical preparations containing them
HU210569B (en) Process for the production of novel acetylcholinesterase inhibitors and pharmaceutical compositions containing the same
JPS61501854A (ja) 新規なド−パミン・アゴニスト
US5254731A (en) Substituted 3,4-dihydronaphthalenes, pharmaceutical compositions containing them, and preparation processes
US5140047A (en) Lipoxygenase inhibitors
US4025649A (en) Acetic acid derivatives having pharmacological activity and compositions containing the same
US5151437A (en) Benzofurancarboxamides having basic substituents and therapeutic agents containing the same
US5356901A (en) Benzofurancarboxamides having basic substituents, the preparation thereof, and therapeutic agents containing them
EP0365210A1 (en) Hydroxamic acid derivatives
EP0481708A1 (en) Indenoindole compounds
US4612317A (en) Tetrahydro-β-carboline dithioic acid derivatives and treatment of liver diseases
EP0267024B1 (en) Hydrofluorene derivatives
JPH08217672A (ja) キサントン誘導体を含有する抗ヘリコバクター・ピロリ薬
US4908361A (en) Tetrahydroisoquino(2,1-C)(1,3)benzodiazepines

Legal Events

Date Code Title Description
RH Patent void